207 related articles for article (PubMed ID: 23218376)
1. Self-assembled nanoparticles of modified-chitosan conjugates for the sustained release of DL-α-tocopherol.
Quiñones JP; Gothelf KV; Kjems J; Yang C; Caballero AM; Schmidt C; Covas CP
Carbohydr Polym; 2013 Jan; 92(1):856-64. PubMed ID: 23218376
[TBL] [Abstract][Full Text] [Related]
2. N,O6-partially acetylated chitosan nanoparticles hydrophobically-modified for controlled release of steroids and vitamin E.
Quiñones JP; Gothelf KV; Kjems J; Caballero ÁM; Schmidt C; Covas CP
Carbohydr Polym; 2013 Jan; 91(1):143-51. PubMed ID: 23044115
[TBL] [Abstract][Full Text] [Related]
3. Self-aggregated nanoparticles from methoxy poly(ethylene glycol)-modified chitosan: synthesis; characterization; aggregation and methotrexate release in vitro.
Yang X; Zhang Q; Wang Y; Chen H; Zhang H; Gao F; Liu L
Colloids Surf B Biointerfaces; 2008 Feb; 61(2):125-31. PubMed ID: 17869489
[TBL] [Abstract][Full Text] [Related]
4. α-Tocopherol succinate-modified chitosan as a micellar delivery system for paclitaxel: preparation, characterization and in vitro/in vivo evaluations.
Liang N; Sun S; Li X; Piao H; Piao H; Cui F; Fang L
Int J Pharm; 2012 Feb; 423(2):480-8. PubMed ID: 22183133
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
[TBL] [Abstract][Full Text] [Related]
6. Self-assembled nanoparticles based on galactosylated O-carboxymethyl chitosan-graft-stearic acid conjugates for delivery of doxorubicin.
Guo H; Zhang D; Li C; Jia L; Liu G; Hao L; Zheng D; Shen J; Li T; Guo Y; Zhang Q
Int J Pharm; 2013 Dec; 458(1):31-8. PubMed ID: 24140544
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of zein/chitosan complex for encapsulation of α-tocopherol, and its in vitro controlled release study.
Luo Y; Zhang B; Whent M; Yu LL; Wang Q
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):145-52. PubMed ID: 21440424
[TBL] [Abstract][Full Text] [Related]
8. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Yu JM; Li YJ; Qiu LY; Jin Y
J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate-incorporated polymeric nanoparticles of methoxy poly(ethylene glycol)-grafted chitosan.
Seo DH; Jeong YI; Kim DG; Jang MJ; Jang MK; Nah JW
Colloids Surf B Biointerfaces; 2009 Mar; 69(2):157-63. PubMed ID: 19135342
[TBL] [Abstract][Full Text] [Related]
10. Retinol-encapsulated low molecular water-soluble chitosan nanoparticles.
Kim DG; Jeong YI; Choi C; Roh SH; Kang SK; Jang MK; Nah JW
Int J Pharm; 2006 Aug; 319(1-2):130-8. PubMed ID: 16713152
[TBL] [Abstract][Full Text] [Related]
11. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
Shu S; Zhang X; Teng D; Wang Z; Li C
Carbohydr Res; 2009 Jul; 344(10):1197-204. PubMed ID: 19508912
[TBL] [Abstract][Full Text] [Related]
12. Quaternized chitosan-organic rectorite intercalated composites based nanoparticles for protein controlled release.
Xu R; Xin S; Zhou X; Li W; Cao F; Feng X; Deng H
Int J Pharm; 2012 Nov; 438(1-2):258-65. PubMed ID: 22982258
[TBL] [Abstract][Full Text] [Related]
13. Preparation of N,O-carboxymethyl chitosan nanoparticles as an insulin carrier.
Lin CC; Lin CW
Drug Deliv; 2009 Nov; 16(8):458-64. PubMed ID: 19839790
[TBL] [Abstract][Full Text] [Related]
14. Polymeric Micelles Based on Modified Glycol Chitosan for Paclitaxel Delivery: Preparation, Characterization and Evaluation.
Liang N; Sun S; Gong X; Li Q; Yan P; Cui F
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29882845
[TBL] [Abstract][Full Text] [Related]
15. Artesunate-loaded chitosan/lecithin nanoparticles: preparation, characterization, and in vivo studies.
Chadha R; Gupta S; Pathak N
Drug Dev Ind Pharm; 2012 Dec; 38(12):1538-46. PubMed ID: 22348223
[TBL] [Abstract][Full Text] [Related]
16. Chitosan/PLGA particles for controlled release of α-tocopherol in the GI tract via oral administration.
Murugeshu A; Astete C; Leonardi C; Morgan T; Sabliov CM
Nanomedicine (Lond); 2011 Nov; 6(9):1513-28. PubMed ID: 21707297
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization and in vitro drug release of magnetic N-benzyl-O-carboxymethylchitosan nanoparticles loaded with indomethacin.
Debrassi A; Bürger C; Rodrigues CA; Nedelko N; Ślawska-Waniewska A; Dłużewski P; Sobczak K; Greneche JM
Acta Biomater; 2011 Aug; 7(8):3078-85. PubMed ID: 21601660
[TBL] [Abstract][Full Text] [Related]
18. Novel amphiphilic chitosan nanocarriers for sustained oral delivery of hydrophobic drugs.
Motiei M; Kashanian S
Eur J Pharm Sci; 2017 Mar; 99():285-291. PubMed ID: 28057549
[TBL] [Abstract][Full Text] [Related]
19. Green synthesis and stabilization of gold nanoparticles in chemically modified chitosan matrices.
Tiwari AD; Mishra AK; Mishra SB; Arotiba OA; Mamba BB
Int J Biol Macromol; 2011 May; 48(4):682-7. PubMed ID: 21349281
[TBL] [Abstract][Full Text] [Related]
20. Chitosan grafted-poly(ethylene glycol) methacrylate nanoparticles as carrier for controlled release of bevacizumab.
Savin CL; Popa M; Delaite C; Costuleanu M; Costin D; Peptu CA
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():843-860. PubMed ID: 30813091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
